KoBioLabs, Inc

KOSDAQ:A348150 Stock Report

Market Cap: ₩62.6b

KoBioLabs Dividends and Buybacks

Dividend criteria checks 0/6

KoBioLabs does not have a record of paying a dividend.

Key information

n/a

Dividend yield

0.0004%

Buyback Yield

Total Shareholder Yield0.0004%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Analysis Article • Dec 10

KoBioLabs, Inc's (KOSDAQ:348150) Shares Leap 26% Yet They're Still Not Telling The Full Story

KoBioLabs, Inc ( KOSDAQ:348150 ) shareholders would be excited to see that the share price has had a great month...
Analysis Article • Nov 14

Is KoBioLabs (KOSDAQ:348150) Weighed On By Its Debt Load?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Sep 02

Market Might Still Lack Some Conviction On KoBioLabs, Inc (KOSDAQ:348150) Even After 36% Share Price Boost

The KoBioLabs, Inc ( KOSDAQ:348150 ) share price has done very well over the last month, posting an excellent gain of...
Analysis Article • Jul 14

KoBioLabs, Inc (KOSDAQ:348150) Screens Well But There Might Be A Catch

You may think that with a price-to-sales (or "P/S") ratio of 1.4x KoBioLabs, Inc ( KOSDAQ:348150 ) is definitely a...
Analysis Article • Apr 09

Take Care Before Diving Into The Deep End On KoBioLabs, Inc (KOSDAQ:348150)

With a price-to-sales (or "P/S") ratio of 1.4x KoBioLabs, Inc ( KOSDAQ:348150 ) may be sending very bullish signals at...
Analysis Article • Nov 13

Take Care Before Diving Into The Deep End On KoBioLabs, Inc (KOSDAQ:348150)

You may think that with a price-to-sales (or "P/S") ratio of 2.1x KoBioLabs, Inc ( KOSDAQ:348150 ) is definitely a...
Analysis Article • Sep 06

Does KoBioLabs (KOSDAQ:348150) Have A Healthy Balance Sheet?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Jul 12

Cautious Investors Not Rewarding KoBioLabs, Inc's (KOSDAQ:348150) Performance Completely

KoBioLabs, Inc's ( KOSDAQ:348150 ) price-to-sales (or "P/S") ratio of 3.7x might make it look like a strong buy right...
Analysis Article • Apr 15

We're Not Worried About KoBioLabsInc's (KOSDAQ:348150) Cash Burn

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Analysis Article • Feb 18

What Type Of Shareholders Own The Most Number of KoBioLabs,Inc (KOSDAQ:348150) Shares?

A look at the shareholders of KoBioLabs,Inc ( KOSDAQ:348150 ) can tell us which group is most powerful. Generally...

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if A348150's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A348150's dividend payments have been increasing.

Dividend Yield vs Market

KoBioLabs Dividend Yield vs Market
How does A348150 dividend yield compare to the market?
SegmentDividend Yield
Company (A348150)n/a
Market Bottom 25% (KR)1.4%
Market Top 25% (KR)4.4%
Industry Average (Biotechs)0.5%
Analyst forecast (A348150) (up to 3 years)n/a

Notable Dividend: Unable to evaluate A348150's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A348150's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate A348150's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A348150 has not reported any payouts.

Discover strong dividend paying companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/15 04:22
End of Day Share Price 2026/07/15 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

KoBioLabs, Inc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.